TITLE

Halogenation Generates Effective Modulators of Amyloid-Beta Aggregation and Neurotoxicity

AUTHOR(S)
Wong, H. Edward; Irwin, Jacob A.; Kwon, Inchan
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Halogenation of organic compounds plays diverse roles in biochemistry, including selective chemical modification of proteins and improved oral absorption/blood-brain barrier permeability of drug candidates. Moreover, halogenation of aromatic molecules greatly affects aromatic interaction-mediated self-assembly processes, including amyloid fibril formation. Perturbation of the aromatic interaction caused by halogenation of peptide building blocks is known to affect the morphology and other physical properties of the fibrillar structure. Consequently, in this article, we investigated the ability of halogenated ligands to modulate the self-assembly of amyloidogenic peptide/protein. As a model system, we chose amyloid-beta peptide (Aβ), which is implicated in Alzheimer’s disease, and a novel modulator of Aβ aggregation, erythrosine B (ERB). Considering that four halogen atoms are attached to the xanthene benzoate group in ERB, we hypothesized that halogenation of the xanthene benzoate plays a critical role in modulating Aβ aggregation and cytotoxicity. Therefore, we evaluated the modulating capacities of four ERB analogs containing different types and numbers of halogen atoms as well as fluorescein as a negative control. We found that fluorescein is not an effective modulator of Aβ aggregation and cytotoxicity. However, halogenation of either the xanthenes or benzoate ring of fluorescein substantially enhanced the inhibitory capacity on Aβ aggregation. Such Aβ aggregation inhibition by ERB analogs except rose bengal correlated well to the inhibition of Aβ cytotoxicity. To our knowledge, this is the first report demonstrating that halogenation of aromatic rings substantially enhance inhibitory capacities of small molecules on Aβ-associated neurotoxicity via Aβ aggregation modulation.
ACCESSION #
87625350

 

Related Articles

  • Cellular prion protein participates in amyloid-β transcytosis across the blood-brain barrier. Pflanzner, Thorsten; Petsch, Benjamin; André-Dohmen, Bettina; Müller-Schiffmann, Andreas; Tschickardt, Sabrina; Weggen, Sascha; Stitz, Lothar; Korth, Carsten; Pietrzik, Claus U // Journal of Cerebral Blood Flow & Metabolism;Apr2012, Vol. 32 Issue 4, p628 

    The blood-brain barrier (BBB) facilitates amyloid-β (Aβ) exchange between the blood and the brain. Here, we found that the cellular prion protein (PrPc), a putative receptor implicated in mediating Aβ neurotoxicity in Alzheimer's disease (AD), participates in Aβ transcytosis across...

  • Identification of beta-amyloid-binding sites on transthyretin. Du, Jiali; Cho, Patricia Y.; Yang, Dennis T.; Murphy, Regina M. // PEDS: Protein Engineering, Design & Selection;Jul2012, Vol. 25 Issue 7, p337 

    Transthyretin (TTR) binds to the Alzheimer-related peptide beta-amyloid (Aβ), and may protect against Aβ-induced neurotoxicity. In this work, the specific domains on TTR involved with binding to Aβ were probed. An array was constructed of peptides derived from overlapping sequences from...

  • The Early Events of α-Synuclein Oligomerization Revealed by Photo- Induced Cross-Linking. Hong-Tao Li; Xiao-Jing Lin; Yuan-Yuan Xie; Hong-Yu Hu // Protein & Peptide Letters;Apr2006, Vol. 13 Issue 4, p385 

    Assembly of α-synuclein (α-Syn) into neurotoxic oligomers and fibrils is an important pathogenic feature of Parkinson's disease. Studying the early events of α-Syn aggregation, such as oligomerization and nucleation, is indispensable to understanding the complicated process. Here,...

  • Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro. Janefjord, Emelie; Mååg, Jesper; Harvey, Benjamin; Smid, Scott // Cellular & Molecular Neurobiology;Jan2014, Vol. 34 Issue 1, p31 

    Cannabinoid (CB) ligands have demonstrated neuroprotective properties. In this study we compared the effects of a diverse set of CB ligands against β amyloid-mediated neuronal toxicity and activated microglial-conditioned media-based neurotoxicity in vitro, and compared this with a capacity...

  • The Role of the Cell Surface LRP and Soluble LRP in Blood-Brain Barrier A� Clearance in Alzheimer's Disease. Deane, R.; Sagare, A.; Zlokovic, B. V. // Current Pharmaceutical Design;Jun2008, Vol. 14 Issue 16, p1601 

    Low-density lipoprotein receptor related protein-1 (LRP) is a member of the low-density lipoprotein (LDL) receptor family which has been linked to Alzheimer's disease (AD) by biochemical and genetic evidence. Levels of neurotoxic amyloid �-peptide (A�) in the brain are elevated in AD...

  • Memapsin 2 (Beta-Secretase) Inhibitors: Drug Development. Ghosh, Arun K.; Kumaragurubaran, Nagaswamy; Ling Hong; Koelsh, Gerald; Tang, Jordan // Current Alzheimer Research;Apr2008, Vol. 5 Issue 2, p121 

    Memapsin 2 (�-secretase, BACE 1) processing of �-amyloid precursor protein is the first step in the pathway leading to the production of amyloid-�, thus, it is a major target for the development of inhibitor drug for the treatment of Alzheimers's Disease. Although there are...

  • Basolateral Aggregated Rat Amyloidβ(1-42) Potentiates Transmigration of Primary Rat Monocytes through a Rat Blood-Brain Barrier. Humpel, Christian // Current Neurovascular Research;Aug2008, Vol. 5 Issue 3, p185 

    Monocytes adhere and transmigrate through a blood-brain barrier (BBB) during a normal immune patrol and after pathological events. It is well established that the transmigration of monocytes through the BBB is stimulated by soluble amyloidß. The aim of the present study was to explore if...

  • RAGE targeted strategies for Alzheimer's amyloid β peptide induced blood brain barrier dysfunctions. Askarova, Sholpan; Tsoy, Andrey; Lee, James C.-M. // Molecular Neurodegeneration;2013, Vol. 8 Issue Suppl 1, p1 

    An abstract of the article " RAGE targeted strategies for Alzheimer's amyloid β peptide induced blood brain barrier dysfunctions" by Sholpan Askarova and colleagues is presented.

  • RAGE mediates amyloid-B peptide transport across the blood-brain barrier and accumulation in brain. Deane, Rashid; Du Yan, Shi; Submamaryan, Ram Kumar; LaRue, Barbara; Jovanovic, Suzana; Hogg, Elizabeth; Welch, Deborah; Manness, Lawrence; Lin, Chang; Yu, Jin; Zhu, Hong; Ghiso, Jorge; Frangione, Blas; Stern, Alan; Schmidt, Ann Marie; Armstrong, Don L; Arnold, Bernd; Liliensiek, Birgit; Nawroth, Peter // Nature Medicine;Jul2003, Vol. 9 Issue 7, p907 

    Amyloid-β peptide (Aβ) interacts with the vasculature to influence Aβ levels in the brain and cerebral blood flow, providing a means of amplifying the Aβ-induced cellular stress underlying neuronal dysfunction and dementia. Systemic Aβ infusion and studies in genetically...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics